On May 10, 2022 Arrakis Therapeutics, a biopharmaceutical company pioneering the discovery of a new class of small molecule medicines that directly target RNA, reported that company management will participate in the following upcoming investor conferences (Press release, Arrakis Therapeutics, MAY 10, 2022, View Source [SID1234614132]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2022 RBC Capital Markets Global Healthcare Conference
Michael Gilman, Ph.D., Chief Executive Officer of Arrakis, will participate in a fireside chat on Tuesday, May 17, 2022 at 10:30 a.m. ET in New York. Company management will also participate in one-on-one meetings.

UBS Global Healthcare Conference 2022
Company management will participate in one-on-one meetings on Monday, May 23, 2022 in New York.